# APAP Hepatotoxicity After Therapeutic Doses

> **NCT03602274** · — · UNKNOWN · sponsor: **University Hospital, Geneva** · enrollment: 96 (estimated)

## Conditions studied

- Paracetamol Toxicity
- Hepatotoxicity
- Malnutrition

## Interventions

- **DIAGNOSTIC_TEST:** Hepatic function monitoring
- **DIAGNOSTIC_TEST:** Nutritional status assesment
- **OTHER:** Biomarker research sampling

## Key facts

- **NCT ID:** NCT03602274
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-02-10
- **Primary completion:** 2018-07
- **Final completion:** 2018-12
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2018-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03602274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03602274, "APAP Hepatotoxicity After Therapeutic Doses". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03602274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*